Search Details

Word: consensus (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...little doubt. In a recent survey released by ABC News on his 100th day in office, he received a 63 percent job approval rating. After a bitter and divisive election, many have argued that Bush is succeeding in his mission to reach across partisan divides and create a united, consensus-based government. Unfortunately, this view is even more flawed than the 43rd president’s grammar...

Author: By Anthony S.A. Freinberg, | Title: Beating Around the Bush | 5/1/2001 | See Source »

...Attorney General and by removing money from overseas charities which discuss abortions, all within his first week in office. Aside from the moral problems of such policies, they do not seem either charitable or a good way to follow his campaign pledge to forge a new style of consensus-based politics...

Author: By Anthony S.A. Freinberg, | Title: Beating Around the Bush | 5/1/2001 | See Source »

...TIME: What about Japan's consensus style of management? Ghosn: A consensus style of management is very good. But I make a distinction between active consensus management and passive. The passive style is a killer...

Author: /time Magazine | Title: Managing to win | 4/30/2001 | See Source »

Improving academic advising for freshman is one of Dean of Freshman Elizabeth Studley Nathans' top priorities, and her rallying behind the cause has brought it to the forefront of College issues. Faculty members have come to a consensus that first-years need better quality advising, echoing dorm room sentiments across the campus...

Author: By Zachary R. Heineman, CRIMSON STAFF WRITER | Title: Peer Academic Advising: Not for First-Years | 4/23/2001 | See Source »

...consensus among drug analysts is that Pfizer will report the highest profit growth for the quarter, up 24% over the same period a year ago. "It's the best of all the drug companies," says portfolio manager David Alger, who owns about $300 million worth of Pfizer in his funds. Merrill Lynch analyst Steve Tighe is high on the new products coming from Pharmacia, which has partnered with Pfizer to launch a new anti-arthritis drug. And he says Elan is attractive since it trades at a discount to large cap and specialty-drug stocks...

Author: /time Magazine | Title: Prescription For The Dow? | 4/23/2001 | See Source »

Previous | 335 | 336 | 337 | 338 | 339 | 340 | 341 | 342 | 343 | 344 | 345 | 346 | 347 | 348 | 349 | 350 | 351 | 352 | 353 | 354 | 355 | Next